Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, Hong Kong, and China. For more information, visit www.deciphera.com.
Company’s Keywords:
How Many Employees Does This Company Have?
330
Which Industry Does This Company Belong To?
pharmaceuticals
What Is the Annual Income?
100215000
What Is the Technology of All the Company’s Website?
DNS Made Easy, Mimecast, Outlook, Drupal, Amazon SES, Pantheon, New Relic, Google Tag Manager, Nginx, Mobile Friendly, Varnish, Vimeo
What Year Was the Company Founded?
2003
Rate us and Write a Review
Own or work here?
Your request has been submitted successfully.
